The pediatric perfusion market size has grown strongly in recent years. It will grow from $2.83 billion in 2025 to $3.09 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rising incidence of congenital heart defects, expansion of pediatric cardiac surgery programs, growing availability of specialized pediatric care centers, increasing survival rates in neonatal intensive care, improvements in extracorporeal circulation techniques.
The pediatric perfusion market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growing investments in pediatric critical care infrastructure, rising adoption of advanced monitoring technologies, increasing focus on minimally invasive pediatric surgeries, expansion of ecmo usage in pediatric respiratory failure, continued innovation in biocompatible perfusion materials. Major trends in the forecast period include increasing adoption of miniaturized pediatric perfusion devices, rising demand for ecmo systems in neonatal care, growing integration of real-time perfusion monitoring, expansion of disposable and single-use perfusion components, enhanced focus on patient-specific perfusion solutions.
The burgeoning prevalence of cardiac congenital disorders is anticipated to propel the growth trajectory of the pediatric perfusion market in the forthcoming years. These disorders, existing at birth, significantly impact heart development and functionality, influencing blood circulation to the body's organs. Pediatric perfusion plays a pivotal role in cardiac surgeries aimed at rectifying structural heart defects, encompassing procedures such as VSD repair, ASD repair, TOF repair, coarctation of the aorta repair, among others. As of February 2023, the World Health Organization highlighted that globally, congenital diseases cause 240,000 newborn deaths within 28 days annually. Correspondingly, the CDC's January 2022 report indicated that approximately 40,000 births in the United States annually are affected by congenital cardiac abnormalities, constituting roughly 1% of the global population. This prevalence remains a driving force behind the growth of the pediatric perfusion sector.
Major companies in the pediatric perfusion market are developing advanced technologies, such as cardiopulmonary bypass (CPB) systems, to improve surgical safety and optimize clinical outcomes for infants and children. Cardiopulmonary bypass (CPB) systems are medical devices that temporarily assume the function of the heart and lungs during surgery, ensuring circulation and oxygenation while the heart is stopped. For instance, in March 2023, LivaNova, a UK-based medical devices manufacturer, introduced the Essenz Heart-Lung Machine in the US region, securing a 510(k) clearance from the U.S. Food and Drug Administration. This sophisticated perfusion system, utilized during cardiopulmonary bypass surgeries, emulates the functions of a patient's heart and lungs during open-heart procedures. Its adaptability for both adult and pediatric patients, along with its mast-mounted design ensuring minimal interference and cleanliness, showcases its effectiveness. The centralized cockpit offers a comprehensive vantage point to manage the device, monitor perfusion and patient data, and seamlessly integrate with external operating room devices and hospital information systems.
In September 2025, OrthoPediatrics Corp., a US-based orthopedic medical device company, signed a distribution agreement with MY01 Inc. to improve patient access and support its global expansion efforts. Through this collaboration, OrthoPediatrics seeks to increase availability of MY01’s Continuous Perfusion Sensing Technology (CPST) Platform, facilitating early detection of acute compartment syndrome and enhancing outcomes in pediatric trauma care. MY01 Inc. is a US-based medical technology company specializing in pediatric perfusion monitoring.
Major companies operating in the pediatric perfusion market are Medtronic plc, Terumo Cardiovascular Systems Corporation, LivaNova PLC, Eurosets, Getinge AB, Edwards Lifesciences Corporation, Smiths Medical Inc., Fresenius Kabi AG, Nipro Medical Corporation, Hemovent GmbH, Spectrum Medical Ltd., Braile Biomédica, Leviticus Cardio Ltd., B. Braun Melsungen AG, Baxter International Inc., ALung Technologies Inc., Novalung GmbH, Xenios AG, Xvivo Perfusion AB, Edwards Lifesciences Corporation.
North America was the largest region in the pediatric perfusion market in 2025. The regions covered in the pediatric perfusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric perfusion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pediatric perfusion market by increasing costs of imported medical-grade polymers, sensors, pumps, oxygenators, and precision-engineered components used in pediatric cannulae, blood pumps, and ECMO systems. Hospitals and pediatric cardiac centers in North America and Europe are most affected due to dependence on specialized imported devices, while Asia-Pacific faces higher procurement costs for advanced perfusion equipment. These tariffs are increasing device acquisition costs and affecting capital budgeting for pediatric care units. However, they are also encouraging localized manufacturing of perfusion disposables, regional supplier partnerships, and investment in domestic production capabilities for critical pediatric life-support systems.
The pediatric perfusion market research report is one of a series of new reports that provides pediatric perfusion market statistics, including pediatric perfusion industry global market size, regional shares, competitors with a pediatric perfusion market share, detailed pediatric perfusion market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric perfusion industry. This pediatric perfusion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pediatric perfusion serves as a critical medical mechanism responsible for circulating blood throughout a pediatric patient's body, ensuring stable blood pressure, adequate oxygen levels, and uniform distribution of blood to all bodily components.
Key pediatric perfusion products encompass pediatric cannulae, pediatric centrifugal blood pumps, pediatric arterial filters, hem concentrators, HMS plus hemostasis management systems, and pediatric oxygenators. Pediatric cannulae, small tubes inserted into a pediatric patient's vein or bodily cavities such as the nose, play a pivotal role in delivering intravenous (IV) therapy. These tools find application in various medical procedures including pediatric cardiac surgeries, organ transplantation in pediatric patients, and pediatric extracorporeal life support (ECLS). End-users such as hospitals, clinics, ambulatory surgical centers, among others, rely on these products for pediatric care.
The pediatric perfusion market consists of sales of heart-lung machines, oxygenators, blood pumps, cannulas, temperature management systems, and monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The pediatric perfusion market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growing investments in pediatric critical care infrastructure, rising adoption of advanced monitoring technologies, increasing focus on minimally invasive pediatric surgeries, expansion of ecmo usage in pediatric respiratory failure, continued innovation in biocompatible perfusion materials. Major trends in the forecast period include increasing adoption of miniaturized pediatric perfusion devices, rising demand for ecmo systems in neonatal care, growing integration of real-time perfusion monitoring, expansion of disposable and single-use perfusion components, enhanced focus on patient-specific perfusion solutions.
The burgeoning prevalence of cardiac congenital disorders is anticipated to propel the growth trajectory of the pediatric perfusion market in the forthcoming years. These disorders, existing at birth, significantly impact heart development and functionality, influencing blood circulation to the body's organs. Pediatric perfusion plays a pivotal role in cardiac surgeries aimed at rectifying structural heart defects, encompassing procedures such as VSD repair, ASD repair, TOF repair, coarctation of the aorta repair, among others. As of February 2023, the World Health Organization highlighted that globally, congenital diseases cause 240,000 newborn deaths within 28 days annually. Correspondingly, the CDC's January 2022 report indicated that approximately 40,000 births in the United States annually are affected by congenital cardiac abnormalities, constituting roughly 1% of the global population. This prevalence remains a driving force behind the growth of the pediatric perfusion sector.
Major companies in the pediatric perfusion market are developing advanced technologies, such as cardiopulmonary bypass (CPB) systems, to improve surgical safety and optimize clinical outcomes for infants and children. Cardiopulmonary bypass (CPB) systems are medical devices that temporarily assume the function of the heart and lungs during surgery, ensuring circulation and oxygenation while the heart is stopped. For instance, in March 2023, LivaNova, a UK-based medical devices manufacturer, introduced the Essenz Heart-Lung Machine in the US region, securing a 510(k) clearance from the U.S. Food and Drug Administration. This sophisticated perfusion system, utilized during cardiopulmonary bypass surgeries, emulates the functions of a patient's heart and lungs during open-heart procedures. Its adaptability for both adult and pediatric patients, along with its mast-mounted design ensuring minimal interference and cleanliness, showcases its effectiveness. The centralized cockpit offers a comprehensive vantage point to manage the device, monitor perfusion and patient data, and seamlessly integrate with external operating room devices and hospital information systems.
In September 2025, OrthoPediatrics Corp., a US-based orthopedic medical device company, signed a distribution agreement with MY01 Inc. to improve patient access and support its global expansion efforts. Through this collaboration, OrthoPediatrics seeks to increase availability of MY01’s Continuous Perfusion Sensing Technology (CPST) Platform, facilitating early detection of acute compartment syndrome and enhancing outcomes in pediatric trauma care. MY01 Inc. is a US-based medical technology company specializing in pediatric perfusion monitoring.
Major companies operating in the pediatric perfusion market are Medtronic plc, Terumo Cardiovascular Systems Corporation, LivaNova PLC, Eurosets, Getinge AB, Edwards Lifesciences Corporation, Smiths Medical Inc., Fresenius Kabi AG, Nipro Medical Corporation, Hemovent GmbH, Spectrum Medical Ltd., Braile Biomédica, Leviticus Cardio Ltd., B. Braun Melsungen AG, Baxter International Inc., ALung Technologies Inc., Novalung GmbH, Xenios AG, Xvivo Perfusion AB, Edwards Lifesciences Corporation.
North America was the largest region in the pediatric perfusion market in 2025. The regions covered in the pediatric perfusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric perfusion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pediatric perfusion market by increasing costs of imported medical-grade polymers, sensors, pumps, oxygenators, and precision-engineered components used in pediatric cannulae, blood pumps, and ECMO systems. Hospitals and pediatric cardiac centers in North America and Europe are most affected due to dependence on specialized imported devices, while Asia-Pacific faces higher procurement costs for advanced perfusion equipment. These tariffs are increasing device acquisition costs and affecting capital budgeting for pediatric care units. However, they are also encouraging localized manufacturing of perfusion disposables, regional supplier partnerships, and investment in domestic production capabilities for critical pediatric life-support systems.
The pediatric perfusion market research report is one of a series of new reports that provides pediatric perfusion market statistics, including pediatric perfusion industry global market size, regional shares, competitors with a pediatric perfusion market share, detailed pediatric perfusion market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric perfusion industry. This pediatric perfusion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pediatric perfusion serves as a critical medical mechanism responsible for circulating blood throughout a pediatric patient's body, ensuring stable blood pressure, adequate oxygen levels, and uniform distribution of blood to all bodily components.
Key pediatric perfusion products encompass pediatric cannulae, pediatric centrifugal blood pumps, pediatric arterial filters, hem concentrators, HMS plus hemostasis management systems, and pediatric oxygenators. Pediatric cannulae, small tubes inserted into a pediatric patient's vein or bodily cavities such as the nose, play a pivotal role in delivering intravenous (IV) therapy. These tools find application in various medical procedures including pediatric cardiac surgeries, organ transplantation in pediatric patients, and pediatric extracorporeal life support (ECLS). End-users such as hospitals, clinics, ambulatory surgical centers, among others, rely on these products for pediatric care.
The pediatric perfusion market consists of sales of heart-lung machines, oxygenators, blood pumps, cannulas, temperature management systems, and monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Pediatric Perfusion Market Characteristics
3. Pediatric Perfusion Market Supply Chain Analysis
4. Global Pediatric Perfusion Market Trends and Strategies
5. Pediatric Perfusion Market Analysis of End Use Industries
7. Global Pediatric Perfusion Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Pediatric Perfusion Total Addressable Market (TAM) Analysis for the Market
9. Pediatric Perfusion Market Segmentation
10. Pediatric Perfusion Market Regional and Country Analysis
11. Asia-Pacific Pediatric Perfusion Market
12. China Pediatric Perfusion Market
13. India Pediatric Perfusion Market
14. Japan Pediatric Perfusion Market
15. Australia Pediatric Perfusion Market
16. Indonesia Pediatric Perfusion Market
17. South Korea Pediatric Perfusion Market
18. Taiwan Pediatric Perfusion Market
19. South East Asia Pediatric Perfusion Market
20. Western Europe Pediatric Perfusion Market
21. UK Pediatric Perfusion Market
22. Germany Pediatric Perfusion Market
23. France Pediatric Perfusion Market
24. Italy Pediatric Perfusion Market
25. Spain Pediatric Perfusion Market
26. Eastern Europe Pediatric Perfusion Market
27. Russia Pediatric Perfusion Market
28. North America Pediatric Perfusion Market
29. USA Pediatric Perfusion Market
30. Canada Pediatric Perfusion Market
31. South America Pediatric Perfusion Market
32. Brazil Pediatric Perfusion Market
33. Middle East Pediatric Perfusion Market
34. Africa Pediatric Perfusion Market
36. Pediatric Perfusion Market Competitive Landscape and Company Profiles
37. Pediatric Perfusion Market Other Major and Innovative Companies
40. Pediatric Perfusion Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Pediatric Perfusion Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pediatric perfusion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pediatric perfusion? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric perfusion market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Pediatric Cannulae; Pediatric Centrifugal Blood Pumps; Pediatric Arterial Filters; Hem concentrators; Pediatric Oxygenators2) By Procedure Type: Pediatric Cardiac Surgeries; Pediatric Organ Transplantation; Pediatric Extracorporeal Life Support (ECLS)
3) By End-User: Hospitals (Tertiary and Pediatric Specialty Hospitals); Pediatric Cardiac and Transplant Centers; Critical Care and ECMO Centers; Academic and Research Medical Centers
Subsegments:
1) By Pediatric Cannulae: Venous Cannulae; Arterial Cannulae; Dual-Lumen Cannulae2) By Pediatric Centrifugal Blood Pumps: Continuous Flow Pumps; Pulsatile Pumps; Disposable Blood Pumps
3) By Pediatric Arterial Filters: Inline Arterial Filters; Bubble Traps; Microaggregate Filters
4) By Hemoconcentrators: Ultra-Filtration Hemoconcentrators; Continuous Renal Replacement Therapy (CRRT) Devices; Dialysis Hemoconcentrators
5) By Pediatric Oxygenators: Membrane Oxygenators; Bubble Oxygenators; Extracorporeal Membrane Oxygenation (ECMO) Systems
Companies Mentioned: Medtronic plc; Terumo Cardiovascular Systems Corporation; LivaNova PLC; Eurosets; Getinge AB; Edwards Lifesciences Corporation; Smiths Medical Inc.; Fresenius Kabi AG; Nipro Medical Corporation; Hemovent GmbH; Spectrum Medical Ltd.; Braile Biomédica; Leviticus Cardio Ltd.; B. Braun Melsungen AG; Baxter International Inc.; ALung Technologies Inc.; Novalung GmbH; Xenios AG; Xvivo Perfusion AB; Edwards Lifesciences Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Pediatric Perfusion market report include:- Medtronic plc
- Terumo Cardiovascular Systems Corporation
- LivaNova PLC
- Eurosets
- Getinge AB
- Edwards Lifesciences Corporation
- Smiths Medical Inc.
- Fresenius Kabi AG
- Nipro Medical Corporation
- Hemovent GmbH
- Spectrum Medical Ltd.
- Braile Biomédica
- Leviticus Cardio Ltd.
- B. Braun Melsungen AG
- Baxter International Inc.
- ALung Technologies Inc.
- Novalung GmbH
- Xenios AG
- Xvivo Perfusion AB
- Edwards Lifesciences Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.09 Billion |
| Forecasted Market Value ( USD | $ 4.39 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
